01345 SH PIONEER HLDG
- 1.840
- -0.010-0.54%
SH PIONEER HLDG News
上海先鋒控股：年報2023
Shanghai Pioneer to Hire New Auditor
Shanghai Pioneer Holding (HKG:1345) intends to hire BDO as its new auditor, subject to shareholders' approval, according to a Wednesday filing with the Hong Kong bourse. BDO will fill the post vacated
Shanghai Pioneer Holdings (01345.HK) plans to appoint Lixin as auditor
On April 24, Ge Longhui | Shanghai Pioneer Holdings (01345.HK) announced that Deloitte Guanhuang Chen Fang Certified Public Accountants (“Deloitte”) will retire as the company's auditor at the end of the company's recent annual general meeting after the end of its current term of office. Following Deloitte's retirement, Hong Kong Lixin Dehao Certified Public Accountants Limited (“Lixin”) was appointed as the company's new auditor, subject to shareholders' approval at the annual shareholders' meeting (Lixin will complete its internal client acceptance procedures prior to the annual shareholders' meeting).
Shanghai Pioneer Holding Ltd (HKG:1345) Stocks Shoot Up 26% But Its P/E Still Looks Reasonable
Shanghai Pioneer Holding Ltd (HKG:1345) shareholders would be excited to see that the share price has had a great month, posting a 26% gain and recovering from prior weakness. Unfortunately, the ga
Earnings Troubles May Signal Larger Issues for Shanghai Pioneer Holding (HKG:1345) Shareholders
The market rallied behind Shanghai Pioneer Holding Ltd's (HKG:1345) stock, leading do a rise in the share price after its recent weak earnings report. We think that shareholders might be missing some
Returns On Capital At Shanghai Pioneer Holding (HKG:1345) Have Stalled
What are the early trends we should look for to identify a stock that could multiply in value over the long term? One common approach is to try and find a company with returns on capital employed (RO
SH PIONEER HLDG To Go Ex-Dividend On May 28th, 2024 With 0.024 HKD Dividend Per Share
March 26th - $SH PIONEER HLDG(01345.HK)$ is trading ex-dividend on May 28th, 2024. Shareholders of record on May 29th, 2024 will receive 0.024 HKD dividend per share on June 19th, 2024. The ex-div
Shanghai Pioneer Holdings (01345) will pay a final dividend of HK$0.024 per share on June 19
Shanghai Pioneer Holdings (01345) announced that the company will distribute until 2023 on June 19, 2024...
Shanghai Pioneer Holdings (01345.HK) annual revenue increased 0.7% to 1,567 billion yuan
Gelonghui March 25 | Shanghai Pioneer Holdings (01345.HK) announced that for the year ended December 31, 2023, the company's revenue increased by 0.7% to RMB 1,566.7 million in 2023. The Group's net profit decreased by 43.9% from RMB 230.0 million in 2022 to RMB 129.0 million in 2023. The Board recommended a year-end dividend of HK$0.024 per share.
SH PIONEER HLDG: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2023
Shanghai Pioneer Holdings (01345.HK) plans to hold a board meeting on March 25 to approve the annual results
Glonghui March 13 | Shanghai Pioneer Holdings (01345.HK) announced that the company will hold a board meeting on March 25, 2024 (Monday) to review (among other things) the annual results of the company and its subsidiaries for the year ended 31 December 2023 and consider payment of a final dividend (if any).
Shanghai Pioneer Holdings (01345) fell 7.90% and now reports 1.640 yuan, a 52-week low
As of 16:08, Shanghai Pioneer Holdings (01345) is down 7.90% from yesterday's closing price and now reports a 52-week low of $1.640; the trading volume is 20,000 shares, with a turnover of HK$32,200.
Shanghai Pioneer Holdings (01345.HK) subsidiary plans to acquire Q3 medical intellectual property rights
Gelonghui, December 27丨Shanghai Pioneer Holdings (01345.HK) announced that recently, Chongqing Pioneer Pharmaceutical Co., Ltd., a subsidiary of the company, signed an intellectual property transfer agreement with Q3 Medical Devices Limited (Q3 Medical Devices Limited). Based on this, Chongqing Pioneer agreed to the acquisition, and Q3 Medical agreed to sell all intellectual property rights (patents and proprietary technology) owned by Q3 Medical up to the date of signing, as well as all rights in newly developed intellectual property rights in mainland China within three years after the signing date. Q3 Healthcare is committed to treating the human body's tubes through micro-intervention
SH PIONEER HLDG: Interim Report 2023
SH PIONEER HLDG To Go Ex-Dividend On October 4th, 2023 With 0.024 HKD Dividend Per Share
August 30th - $SH PIONEER HLDG(01345.HK)$ is trading ex-dividend on October 4th, 2023. Shareholders of record on October 5th, 2023 will receive 0.024 HKD dividend per share on October 20th, 2023.
Shanghai Pioneer Holdings (01345.HK)'s revenue for the first half of the year increased 11.8% to 736.9 million yuan
Glonghui, August 29丨Shanghai Pioneer Holdings (01345.HK) announced its interim results. For the six months ended June 30, 2023, revenue increased 11.8% to RMB 763.9 million. Drug revenue sold through the provision of comprehensive marketing, promotion and channel management services decreased by 52.3% from RMB 429.1 million for the six months ending June 30, 2022. As for RMB 204.9 million during the reporting period, it was mainly due to lower sales prices for some products during the reporting period and the slow recovery of market sales of individual products after the COVID-19 pandemic. By providing comprehensiveness
SH PIONEER HLDG: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2023
Shanghai Pioneer Holdings (01345.HK) plans to hold a board meeting on August 29 to approve interim results
GLONGHUI, August 17丨Shanghai Pioneer Holdings (01345.HK) announced that the company will hold a board meeting on August 29, 2023 (Tuesday) to (including) approve the company's and its subsidiaries' interim results and announcements for the six months ended June 30, 2023, and consider paying interim dividends (if any).
SH PIONEER HLDG: NOTICE OF BOARD MEETING
With EPS Growth And More, Shanghai Pioneer Holding (HKG:1345) Makes An Interesting Case
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to investors, even if it currently lacks a track record of revenue and profit. But as P
Analysis
Price Target
No Data
